Header Logo

Connection

WOLFGANG WINKELMAYER to Renal Dialysis

Back to Details
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Renal Dialysis.
WOLFGANG WINKELMAYER
Connection Strength
26.875
Renal Dialysis
  1. Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids. J Am Soc Nephrol. 2020 06; 31(6):1325-1334.
    View in: PubMed
    Score: 0.438
  2. The dialysis care-policy issue: Guest Editors' introductory remarks. Semin Dial. 2020 01; 33(1):4.
    View in: PubMed
    Score: 0.428
  3. Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis. Am J Kidney Dis. 2020 03; 75(3):351-360.
    View in: PubMed
    Score: 0.421
  4. Blood Pressure and Incident Atrial Fibrillation in Older Patients Initiating Hemodialysis. Clin J Am Soc Nephrol. 2019 07 05; 14(7):1029-1038.
    View in: PubMed
    Score: 0.411
  5. Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure? JAMA. 2018 12 04; 320(21):2206-2208.
    View in: PubMed
    Score: 0.397
  6. Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD. Am J Kidney Dis. 2019 03; 73(3):324-331.
    View in: PubMed
    Score: 0.395
  7. Evaluating the Evidence behind Policy Mandates in US Dialysis Care. J Am Soc Nephrol. 2018 12; 29(12):2777-2779.
    View in: PubMed
    Score: 0.394
  8. Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
    View in: PubMed
    Score: 0.394
  9. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1534-1541.
    View in: PubMed
    Score: 0.391
  10. Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. Nephrol Dial Transplant. 2018 09 01; 33(9):1590-1597.
    View in: PubMed
    Score: 0.390
  11. The Role of Big Data in the Development and Evaluation of US Dialysis Care. Am J Kidney Dis. 2018 10; 72(4):560-568.
    View in: PubMed
    Score: 0.384
  12. Market Competition and Health Outcomes in Hemodialysis. Health Serv Res. 2018 10; 53(5):3680-3703.
    View in: PubMed
    Score: 0.376
  13. Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273.
    View in: PubMed
    Score: 0.373
  14. Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus. J Am Heart Assoc. 2017 Jun 07; 6(6).
    View in: PubMed
    Score: 0.358
  15. Nephrologists' Perspectives on Defining and Applying Patient-Centered Outcomes in Hemodialysis. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):454-466.
    View in: PubMed
    Score: 0.350
  16. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex. Am J Kidney Dis. 2017 Jun; 69(6):771-779.
    View in: PubMed
    Score: 0.347
  17. Predicting mortality over different time horizons: which data elements are needed? J Am Med Inform Assoc. 2017 01; 24(1):176-181.
    View in: PubMed
    Score: 0.335
  18. Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis. J Am Coll Cardiol. 2016 Mar 29; 67(12):1459-1469.
    View in: PubMed
    Score: 0.329
  19. Differences in Initial Hemodialysis Vascular Access Use Among Glomerulonephritis Subtypes in the United States. Am J Kidney Dis. 2016 Apr; 67(4):638-47.
    View in: PubMed
    Score: 0.324
  20. Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease. BMC Nephrol. 2015 Dec 09; 16:204.
    View in: PubMed
    Score: 0.322
  21. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA. Nephrol Dial Transplant. 2016 Feb; 31(2):290-8.
    View in: PubMed
    Score: 0.322
  22. The Dawning of a New Day in CKD Anemia Care? J Am Soc Nephrol. 2016 Apr; 27(4):968-70.
    View in: PubMed
    Score: 0.319
  23. Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. Nephrol Dial Transplant. 2015 Dec; 30(12):2068-75.
    View in: PubMed
    Score: 0.316
  24. Classifying individuals based on a densely captured sequence of vital signs: An example using repeated blood pressure measurements during hemodialysis treatment. J Biomed Inform. 2015 Oct; 57:219-24.
    View in: PubMed
    Score: 0.315
  25. Timing of Dialysis Initiation-Do Health Care Setting or Provider Incentives Matter? Clin J Am Soc Nephrol. 2015 Aug 07; 10(8):1321-3.
    View in: PubMed
    Score: 0.314
  26. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation. Am J Kidney Dis. 2015 Oct; 66(4):677-88.
    View in: PubMed
    Score: 0.313
  27. Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1170-8.
    View in: PubMed
    Score: 0.312
  28. Heparin use in hemodialysis patients following gastrointestinal bleeding. Am J Nephrol. 2014; 40(4):300-7.
    View in: PubMed
    Score: 0.298
  29. Commentary on 'the DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients': the calm before the 2016 storm? Am J Kidney Dis. 2014 May; 63(5):854-8.
    View in: PubMed
    Score: 0.288
  30. Cardiovascular disease: Still unresolved: warfarin in ESRD with atrial fibrillation. Nat Rev Nephrol. 2014 May; 10(5):244-5.
    View in: PubMed
    Score: 0.286
  31. Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):515-25.
    View in: PubMed
    Score: 0.285
  32. IV iron dosing regimens: choice of agent and dosing frequency. Nephrol News Issues. 2014 Feb; 28(2):10-1, 18.
    View in: PubMed
    Score: 0.284
  33. Thematic synthesis of qualitative studies on patient and caregiver perspectives on end-of-life care in CKD. Am J Kidney Dis. 2014 Jun; 63(6):913-27.
    View in: PubMed
    Score: 0.282
  34. Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States. Clin J Am Soc Nephrol. 2013 Aug; 8(8):1336-42.
    View in: PubMed
    Score: 0.270
  35. Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System. Am J Kidney Dis. 2013 Aug; 62(2):312-21.
    View in: PubMed
    Score: 0.269
  36. Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC Nephrol. 2013 Apr 26; 14:97.
    View in: PubMed
    Score: 0.269
  37. Use and safety of heparin-free maintenance hemodialysis in the USA. Nephrol Dial Transplant. 2013 Jun; 28(6):1589-602.
    View in: PubMed
    Score: 0.268
  38. Assessments of causal effects--theoretically sound, practically unattainable, and clinically not so relevant. Clin J Am Soc Nephrol. 2013 Apr; 8(4):520-2.
    View in: PubMed
    Score: 0.267
  39. Commentary on 'The DOPPS Practice Monitor for US dialysis care: trends through December 2011': results from year one. Am J Kidney Dis. 2013 Feb; 61(2):346-8.
    View in: PubMed
    Score: 0.265
  40. Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Ann Thorac Surg. 2013 Jan; 95(1):20-8.
    View in: PubMed
    Score: 0.263
  41. Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks? Curr Opin Nephrol Hypertens. 2012 Nov; 21(6):600-6.
    View in: PubMed
    Score: 0.260
  42. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation. 2012 Nov 06; 126(19):2293-301.
    View in: PubMed
    Score: 0.259
  43. Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis. Am J Kidney Dis. 2012 Sep; 60(3):473-86.
    View in: PubMed
    Score: 0.251
  44. Commentary on 'The DOPPS practice monitor for US dialysis care: trends through August 2011': an ESA confluence. Am J Kidney Dis. 2012 Jul; 60(1):165-7.
    View in: PubMed
    Score: 0.251
  45. Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol. 2012 May-Jun; 25(3):341-53.
    View in: PubMed
    Score: 0.251
  46. Validation of reported predialysis nephrology care of older patients initiating dialysis. J Am Soc Nephrol. 2012 Jun; 23(6):1078-85.
    View in: PubMed
    Score: 0.251
  47. Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005). J Nephrol. 2013 Mar-Apr; 26(2):281-8.
    View in: PubMed
    Score: 0.249
  48. Commentary on 'The DOPPS practice monitor for US dialysis care: trends through April 2011': no surprises yet. Am J Kidney Dis. 2012 Feb; 59(2):312-4.
    View in: PubMed
    Score: 0.247
  49. Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients. J Am Soc Nephrol. 2012 Mar; 23(3):495-506.
    View in: PubMed
    Score: 0.246
  50. Altitude and the risk of cardiovascular events in incident US dialysis patients. Nephrol Dial Transplant. 2012 Jun; 27(6):2411-7.
    View in: PubMed
    Score: 0.246
  51. Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States. Clin J Am Soc Nephrol. 2012 Feb; 7(2):289-96.
    View in: PubMed
    Score: 0.244
  52. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2662-8.
    View in: PubMed
    Score: 0.241
  53. Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011 Aug 08; 171(15):1371-8.
    View in: PubMed
    Score: 0.239
  54. Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. Am Heart J. 2011 Aug; 162(2):324-30.
    View in: PubMed
    Score: 0.238
  55. The effect of altitude change on anemia treatment response in hemodialysis patients. Am J Epidemiol. 2011 Apr 01; 173(7):768-77.
    View in: PubMed
    Score: 0.231
  56. The 2011 ESRD prospective payment system: an uncontrolled experiment. Am J Kidney Dis. 2011 Apr; 57(4):542-6.
    View in: PubMed
    Score: 0.231
  57. Tackling the Achilles' heel of hemodialysis. N Engl J Med. 2011 Jan 27; 364(4):372-4.
    View in: PubMed
    Score: 0.230
  58. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2011 Feb; 22(2):349-57.
    View in: PubMed
    Score: 0.230
  59. Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients. Clin J Am Soc Nephrol. 2011 Jan; 6(1):175-83.
    View in: PubMed
    Score: 0.226
  60. Confusion about the appropriate use of erythropoiesis-stimulating agents in patients undergoing maintenance dialysis. Semin Dial. 2010 Sep-Oct; 23(5):486-91.
    View in: PubMed
    Score: 0.224
  61. Chronic on acute renal failure: long-term implications of severe acute kidney injury. JAMA. 2009 Sep 16; 302(11):1227-9.
    View in: PubMed
    Score: 0.209
  62. Altitude and all-cause mortality in incident dialysis patients. JAMA. 2009 Feb 04; 301(5):508-12.
    View in: PubMed
    Score: 0.201
  63. Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice. Am J Kidney Dis. 2008 Mar; 51(3):362-5.
    View in: PubMed
    Score: 0.188
  64. Benzodiazepine use and mortality of incident dialysis patients in the United States. Kidney Int. 2007 Dec; 72(11):1388-93.
    View in: PubMed
    Score: 0.182
  65. Predialysis nephrologist care and access to kidney transplantation in the United States. Am J Transplant. 2007 Apr; 7(4):872-9.
    View in: PubMed
    Score: 0.177
  66. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int. 2007 Jan; 71(2):153-8.
    View in: PubMed
    Score: 0.172
  67. Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure. Clin J Am Soc Nephrol. 2006 May; 1(3):455-61.
    View in: PubMed
    Score: 0.165
  68. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Am J Kidney Dis. 2006 Feb; 47(2):301-8.
    View in: PubMed
    Score: 0.163
  69. Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 09; 104(3):441-454.
    View in: PubMed
    Score: 0.135
  70. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003 Feb; 14(2):486-92.
    View in: PubMed
    Score: 0.132
  71. Fifty Years of a National Program for the Treatment of Kidney Failure. JAMA. 2023 01 17; 329(3):205-206.
    View in: PubMed
    Score: 0.132
  72. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol. 2002 Sep; 13(9):2353-62.
    View in: PubMed
    Score: 0.129
  73. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002 Sep-Oct; 22(5):417-30.
    View in: PubMed
    Score: 0.129
  74. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol. 2022 01 01; 7(1):75-83.
    View in: PubMed
    Score: 0.123
  75. Patient Health Outcomes following Dialysis Facility Closures in the United States. J Am Soc Nephrol. 2021 10; 32(10):2613-2621.
    View in: PubMed
    Score: 0.121
  76. Late referral and modality choice in end-stage renal disease. Kidney Int. 2001 Oct; 60(4):1547-54.
    View in: PubMed
    Score: 0.121
  77. The Association of Pre-Kidney Transplant Dialysis Modality with de novo Posttransplant Heart Failure. Cardiorenal Med. 2021; 11(5-6):209-217.
    View in: PubMed
    Score: 0.120
  78. Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clin J Am Soc Nephrol. 2021 07; 16(7):1052-1060.
    View in: PubMed
    Score: 0.119
  79. Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis. N Engl J Med. 2021 04 29; 384(17):1601-1612.
    View in: PubMed
    Score: 0.117
  80. Intradialytic Hypotension and Newly Recognized Peripheral Artery Disease in Patients Receiving Hemodialysis. Am J Kidney Dis. 2021 05; 77(5):730-738.
    View in: PubMed
    Score: 0.114
  81. Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020 10 01; 35(10):1761-1769.
    View in: PubMed
    Score: 0.113
  82. Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. J Am Heart Assoc. 2020 07 07; 9(13):e015969.
    View in: PubMed
    Score: 0.110
  83. Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop. Am J Kidney Dis. 2020 07; 76(1):109-120.
    View in: PubMed
    Score: 0.110
  84. Bundled Payment Reform and Dialysis Facility Closures in ESKD. J Am Soc Nephrol. 2020 03; 31(3):579-590.
    View in: PubMed
    Score: 0.108
  85. Safety-Net Care for Maintenance Dialysis in the United States. J Am Soc Nephrol. 2020 02; 31(2):424-433.
    View in: PubMed
    Score: 0.107
  86. Trends in the Medical Complexity and Outcomes of Medicare-insured Patients Undergoing Kidney Transplant in the Years 1998-2014. Transplantation. 2019 11; 103(11):2413-2422.
    View in: PubMed
    Score: 0.106
  87. Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions. JAMA Netw Open. 2019 05 03; 2(5):e193987.
    View in: PubMed
    Score: 0.102
  88. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 06; 95(6):1304-1317.
    View in: PubMed
    Score: 0.102
  89. The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration. J Am Soc Nephrol. 2019 05; 30(5):890-903.
    View in: PubMed
    Score: 0.102
  90. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 07; 96(1):37-47.
    View in: PubMed
    Score: 0.102
  91. Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review. J Med Econ. 2019 Jun; 22(6):593-604.
    View in: PubMed
    Score: 0.101
  92. Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation. Semin Nephrol. 2018 11; 38(6):618-628.
    View in: PubMed
    Score: 0.099
  93. Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System. JAMA Intern Med. 2018 10 01; 178(10):1358-1367.
    View in: PubMed
    Score: 0.098
  94. The Relationship between Intradialytic Hypotension and Hospitalized Mesenteric Ischemia: A Case-Control Study. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1517-1525.
    View in: PubMed
    Score: 0.098
  95. Heterogeneity in Outcomes Among ?-Blockers Elucidated by Intradialytic Data. Am J Kidney Dis. 2018 09; 72(3):318-321.
    View in: PubMed
    Score: 0.097
  96. Market Consolidation and Mortality in Patients Initiating Hemodialysis. Value Health. 2019 01; 22(1):69-76.
    View in: PubMed
    Score: 0.097
  97. Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant. 2018 07 01; 33(7):1207-1214.
    View in: PubMed
    Score: 0.096
  98. Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study. BMJ Open. 2018 04 20; 8(4):e021198.
    View in: PubMed
    Score: 0.095
  99. Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review. Am J Kidney Dis. 2018 07; 72(1):62-74.
    View in: PubMed
    Score: 0.094
  100. Hospitalizations and Nursing Facility Stays During the Transition from CKD to ESRD on Dialysis: An Observational Study. J Gen Intern Med. 2017 Nov; 32(11):1220-1227.
    View in: PubMed
    Score: 0.091
  101. A Case for More Frequent, Not Just Earlier, Nephrology Care of Patients Approaching ESRD? Am J Kidney Dis. 2017 08; 70(2):155-157.
    View in: PubMed
    Score: 0.090
  102. Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey. Am J Kidney Dis. 2017 Oct; 70(4):464-475.
    View in: PubMed
    Score: 0.088
  103. Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2017 Feb; 69(2):266-277.
    View in: PubMed
    Score: 0.086
  104. Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform. Am J Kidney Dis. 2017 Feb; 69(2):237-246.
    View in: PubMed
    Score: 0.086
  105. Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):536-545.
    View in: PubMed
    Score: 0.086
  106. Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease. Trials. 2016 08 12; 17:401.
    View in: PubMed
    Score: 0.084
  107. Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop. Am J Kidney Dis. 2017 Jan; 69(1):97-107.
    View in: PubMed
    Score: 0.084
  108. Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique Study. Am J Kidney Dis. 2016 Sep; 68(3):444-54.
    View in: PubMed
    Score: 0.082
  109. Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform. J Am Soc Nephrol. 2016 Oct; 27(10):3129-3138.
    View in: PubMed
    Score: 0.082
  110. Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using medicare data. BMC Nephrol. 2016 Feb 09; 17:16.
    View in: PubMed
    Score: 0.082
  111. Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related?Quality of Life in Patients Receiving?Hemodialysis. Am J Kidney Dis. 2016 Feb; 67(2):271-82.
    View in: PubMed
    Score: 0.080
  112. Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients. Am J Kidney Dis. 2016 Jan; 67(1):119-27.
    View in: PubMed
    Score: 0.079
  113. Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis. Trials. 2015 Aug 19; 16:364.
    View in: PubMed
    Score: 0.079
  114. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. Am J Kidney Dis. 2015 Jul; 66(1):106-13.
    View in: PubMed
    Score: 0.077
  115. Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis. Am J Kidney Dis. 2015 Jul; 66(1):69-74.
    View in: PubMed
    Score: 0.076
  116. Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77.
    View in: PubMed
    Score: 0.076
  117. Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. J Am Soc Nephrol. 2015 Aug; 26(8):1990-7.
    View in: PubMed
    Score: 0.075
  118. Patients' perspectives on hemodialysis vascular access: a systematic review of qualitative studies. Am J Kidney Dis. 2014 Dec; 64(6):937-53.
    View in: PubMed
    Score: 0.073
  119. Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2014 Sep; 25(9):2079-87.
    View in: PubMed
    Score: 0.072
  120. State medicaid coverage, ESRD incidence, and access to care. J Am Soc Nephrol. 2014 Jun; 25(6):1321-9.
    View in: PubMed
    Score: 0.072
  121. Prognostic stratification in older adults commencing dialysis. J Gerontol A Biol Sci Med Sci. 2014 Aug; 69(8):1033-9.
    View in: PubMed
    Score: 0.071
  122. Coronary artery bypass graft type and outcomes in maintenance dialysis. J Cardiovasc Surg (Torino). 2015 Jun; 56(3):463-71.
    View in: PubMed
    Score: 0.070
  123. Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients. PLoS One. 2013; 8(11):e78930.
    View in: PubMed
    Score: 0.070
  124. Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records. Clin J Am Soc Nephrol. 2014 Jan; 9(1):82-91.
    View in: PubMed
    Score: 0.070
  125. Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2213-20.
    View in: PubMed
    Score: 0.069
  126. Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol. 2013 Jun; 24(7):1151-8.
    View in: PubMed
    Score: 0.068
  127. The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med. 2013 Jun; 126(6):541.e1-541.e14.
    View in: PubMed
    Score: 0.067
  128. Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol. 2013 Jun; 8(6):987-94.
    View in: PubMed
    Score: 0.066
  129. Predialyis nephrology care of older individuals approaching end-stage renal disease. Semin Dial. 2012 Nov-Dec; 25(6):628-32.
    View in: PubMed
    Score: 0.065
  130. The challenges of cost-effectiveness analyses for the clinician. Am J Kidney Dis. 2010 Dec; 56(6):1023-5.
    View in: PubMed
    Score: 0.057
  131. Off-label use of phosphate binders in non-dialysis-dependent CKD. Am J Kidney Dis. 2010 Nov; 56(5):813-6.
    View in: PubMed
    Score: 0.057
  132. Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA. 2010 Mar 03; 303(9):857-64.
    View in: PubMed
    Score: 0.054
  133. Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials. Transplantation. 2009 Dec 27; 88(12):1377-85.
    View in: PubMed
    Score: 0.053
  134. Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL. Pharmacoepidemiol Drug Saf. 2009 Oct; 18(10):932-40.
    View in: PubMed
    Score: 0.052
  135. Predicting survival in patients requiring renal replacement therapy after cardiac surgery. Ann Thorac Surg. 2006 Apr; 81(4):1385-92.
    View in: PubMed
    Score: 0.041
  136. Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial. Nat Med. 2024 Feb; 30(2):435-442.
    View in: PubMed
    Score: 0.036
  137. Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis. Nephrol Dial Transplant. 2023 09 29; 38(10):2358-2367.
    View in: PubMed
    Score: 0.035
  138. The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients. Kidney Int. 2003 Jul; 64(1):295-304.
    View in: PubMed
    Score: 0.034
  139. Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 12; 104(6):1076-1091.
    View in: PubMed
    Score: 0.034
  140. Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group. Kidney Int. 2023 06; 103(6):1028-1037.
    View in: PubMed
    Score: 0.033
  141. Iron Sucrose and Blood Pressure Patterns During Hemodialysis. Am J Kidney Dis. 2023 06; 81(6):629-631.
    View in: PubMed
    Score: 0.033
  142. Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 05; 103(5):842-858.
    View in: PubMed
    Score: 0.033
  143. Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials. Am J Nephrol. 2022; 53(10):701-710.
    View in: PubMed
    Score: 0.033
  144. Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease. JAMA. 2022 11 08; 328(18):1837-1848.
    View in: PubMed
    Score: 0.033
  145. Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial. Circulation. 2022 12 06; 146(23):1735-1745.
    View in: PubMed
    Score: 0.033
  146. The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study. Nephrol Dial Transplant. 2022 10 19; 37(11):2241-2252.
    View in: PubMed
    Score: 0.032
  147. Association of Bradycardia and Asystole Episodes with Dialytic Parameters: An Analysis of the Monitoring in Dialysis (MiD) Study. Kidney360. 2022 11 24; 3(11):1871-1880.
    View in: PubMed
    Score: 0.032
  148. A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov; 33(11):2059-2070.
    View in: PubMed
    Score: 0.032
  149. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002 Jul; 55(7):711-6.
    View in: PubMed
    Score: 0.032
  150. Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure. Kidney Int. 2022 10; 102(4):894-903.
    View in: PubMed
    Score: 0.032
  151. Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiol Drug Saf. 2022 06; 31(6):670-679.
    View in: PubMed
    Score: 0.031
  152. Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States. J Am Soc Nephrol. 2022 06; 33(6):1063-1072.
    View in: PubMed
    Score: 0.031
  153. Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials. Nephrol Dial Transplant. 2021 11 09; 36(11):2039-2048.
    View in: PubMed
    Score: 0.030
  154. Ultrafiltration rate and incident atrial fibrillation among older individuals initiating hemodialysis. Nephrol Dial Transplant. 2021 11 09; 36(11):2084-2093.
    View in: PubMed
    Score: 0.030
  155. Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target. Kidney Int. 2021 12; 100(6):1199-1207.
    View in: PubMed
    Score: 0.030
  156. Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population-based prospective cohort study. J Thromb Haemost. 2021 12; 19(12):2984-2996.
    View in: PubMed
    Score: 0.030
  157. Optic neuropathy in uremia: an interdisciplinary emergency. Am J Kidney Dis. 2001 Mar; 37(3):E23.
    View in: PubMed
    Score: 0.029
  158. Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease. Expert Opin Investig Drugs. 2000 Nov; 9(11):2637-51.
    View in: PubMed
    Score: 0.028
  159. Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics. Am Heart J. 2021 05; 235:1-11.
    View in: PubMed
    Score: 0.028
  160. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol. 2000 Jun; 11(6):1106-1116.
    View in: PubMed
    Score: 0.027
  161. Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020 05; 97(5):861-876.
    View in: PubMed
    Score: 0.027
  162. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol. 2020; 51(3):172-181.
    View in: PubMed
    Score: 0.027
  163. Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population. J Am Soc Nephrol. 2019 02; 30(2):346-353.
    View in: PubMed
    Score: 0.025
  164. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
    View in: PubMed
    Score: 0.024
  165. Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur Heart J. 2018 06 21; 39(24):2314-2325.
    View in: PubMed
    Score: 0.024
  166. Cardiovascular Outcomes Reported in Hemodialysis Trials. J Am Coll Cardiol. 2018 06 19; 71(24):2802-2810.
    View in: PubMed
    Score: 0.024
  167. A comparison of risk prediction methods using repeated observations: an application to electronic health records for hemodialysis. Stat Med. 2017 Jul 30; 36(17):2750-2763.
    View in: PubMed
    Score: 0.022
  168. Phosphate Binders: The Evidence Gap Persists. Am J Kidney Dis. 2016 11; 68(5):667-670.
    View in: PubMed
    Score: 0.021
  169. Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis. Clin J Am Soc Nephrol. 2016 08 08; 11(8):1401-1412.
    View in: PubMed
    Score: 0.021
  170. Effects of physician payment reform on provision of home dialysis. Am J Manag Care. 2016 06 01; 22(6):e215-23.
    View in: PubMed
    Score: 0.021
  171. Perspectives on Pregnancy in Women With CKD: A Semistructured Interview Study. Am J Kidney Dis. 2015 Dec; 66(6):951-61.
    View in: PubMed
    Score: 0.020
  172. Detecting clinically meaningful biomarkers with repeated measurements: An illustration with electronic health records. Biometrics. 2015 Jun; 71(2):478-86.
    View in: PubMed
    Score: 0.019
  173. Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2149-57.
    View in: PubMed
    Score: 0.017
  174. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1642-53.
    View in: PubMed
    Score: 0.015
  175. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 2011 Jun; 63(6):1681-8.
    View in: PubMed
    Score: 0.015
  176. A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease. BMC Nephrol. 2011 Feb 16; 12:9.
    View in: PubMed
    Score: 0.014
  177. No associations between prolactin concentrations and response to erythropoiesis-stimulating agents in hemodialysis patients. Am J Nephrol. 2007; 27(4):390-6.
    View in: PubMed
    Score: 0.011
  178. Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease. Pediatr Nephrol. 2007 Aug; 22(8):1189-93.
    View in: PubMed
    Score: 0.011
  179. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002 Sep 23; 162(17):2002-6.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.